At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. As a Senior Director – Inflammation , at Gilead you will lead early commercialization strategy for pipeline assets across inflammation and immunology, representing the commercial perspective from pre‑clinical development through early and mid‑stage clinical programs. Reporting to the Vice President, Global Commercial Liver, Inflammation, COVID‑19 and Established Products, this role is accountable for guiding pre‑proof‑of‑concept (pre‑POC) and early commercialization activities to inform development decisions, product profiles, and investment priorities. The role operates in a highly cross‑functional environment and is responsible for integrating market, payer, provider, patient, and competitive insights into development strategy to maximize long‑term patient impact and commercial value.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director